Motive Wealth Advisors Invests $224,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Motive Wealth Advisors purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 430 shares of the medical equipment provider's stock, valued at approximately $224,000.

Other large investors have also recently made changes to their positions in the company. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the 4th quarter valued at $36,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $38,000. Finally, DT Investment Partners LLC boosted its position in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after buying an additional 36 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Jamie Samath sold 22,903 shares of the company's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,475 shares of company stock worth $22,070,807. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a report on Friday. Finally, Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $583.83.

Intuitive Surgical Stock Down 4.4 %

Shares of NASDAQ ISRG traded down $26.75 during trading on Friday, reaching $581.91. The company had a trading volume of 3,080,909 shares, compared to its average volume of 1,909,580. The business's 50-day moving average is $546.03 and its 200 day moving average is $503.38. The stock has a market cap of $207.27 billion, a PE ratio of 93.62, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.